In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal title
Antimicrobial agents and chemotherapyDate Published
1999-11Publication Volume
43Publication Issue
11Publication Begin page
2806Publication End page
7
Metadata
Show full item recordAbstract
We compared the in vitro activity of gemifloxacin, a new quinolone antibiotic, to the activities of levofloxacin, moxifloxacin, trovafloxacin, erythromycin, and doxycycline against 20 isolates of Chlamydia pneumoniae. Gemifloxacin was the most active quinolone tested, with a MIC at which 90% of the isolates are inhibited and a minimal bactericidal concentration at which 90% of strains tested are killed of 0.25 microg/ml, but this activity was less than those of doxycycline and erythromycin.Citation
Roblin PM, Reznik T, Kutlin A, Hammerschlag MR. In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae. Antimicrob Agents Chemother. 1999 Nov;43(11):2806-7. doi: 10.1128/AAC.43.11.2806. PMID: 10543770; PMCID: PMC89566.Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- In vitro activity of trovafloxacin against Chlamydia pneumoniae.
- Authors: Roblin PM, Kutlin A, Hammerschlag MR
- Issue date: 1997 Sep
- Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens.
- Authors: García-Garrote F, Cercenado E, Martín-Pedroviejo J, Cuevas O, Bouza E
- Issue date: 2001 May
- Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
- Authors: Davies TA, Kelly LM, Pankuch GA, Credito KL, Jacobs MR, Appelbaum PC
- Issue date: 2000 Feb
- Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model.
- Authors: Kutlin A, Roblin PM, Hammerschlag MR
- Issue date: 2002 May
- Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.
- Authors: Waites KB, Crabb DM, Duffy LB
- Issue date: 2003 Jun